Neo Ivy Capital Management Johnson & Johnson Transaction History

Neo Ivy Capital Management

$505 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 23, 2024	BUY	$145.6 - $158.88 $920,483 - $1 Million	6,322 New	6,322 $991,000
Q4 2022 Mar 24, 2023	BUY	$160.2 - $179.79 $436,384 - $489,747	2,724 New	2,724 $481,000
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $589,229 - $669,152	-3,726 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$155.93 - $173.01 $313,263 - $347,577	-2,009 Reduced 35.03%	3,726 $637,000
Q3 2021 Nov 16, 2021	BUY	$161.5 - $179.47 $76,228 - $84,709	472 Added 8.97%	5,735 $807,000
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $839,343 - $900,341	5,263 New	5,263 $867,000
Q1 2021 Oct 07, 2021	SELL	$153.07 - $170.48 $856,885 - $954,347	-5,598 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $549,948 - $631,251	4,011 Added 252.74%	5,598 $881,000
Q3 2020 Nov 17, 2020	SELL	$140.38 - $153.83 $644,063 - $705,772	-4,588 Reduced 74.3%	1,587 $236,000
Q2 2020 Aug 17, 2020	BUY	$128.81 - $155.51 $56,676 - $68,424	440 Added 7.67%	6,175 $868,000
Q2 2020 Aug 17, 2020	BUY	$128.81 - $155.51 $738,725 - $891,849	5,735 New	5,735 $807,000
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $15,226 - $21,096	-137 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $1.26 Million - $1.44 Million	-9,863 Reduced 98.63%	137 $20,000
Q3 2019 Nov 21, 2019	BUY	$126.95 - $142.14 $485,583 - $543,685	3,825 Added 61.94%	10,000 $1.28 Million
Q2 2019 Aug 15, 2019	BUY	$131.15 - $144.24 $799,359 - $879,142	6,095 Added 7618.75%	6,175 $860,000
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $1.08 Million - $1.2 Million	-8,602 Reduced 99.08%	80 $11,000
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $1.07 Million - $1.28 Million	8,682 New	8,682 $1.12 Million

Others Institutions Holding JNJ

# of Institutions

4,162

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $424B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.

Account